Stage FocusSeed, Series A, Series B+
GeographyEurope
TypeVC
Last Activity-
Industry Focus
Industries
Biotech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Aglaia Oncology Funds is a Bilthoven, Netherlands-based venture firm that has invested in oncology drug development since 2004. The team, led by partners Karl Rothweiler, Folkert van Cleef, Eric van der Putten and Mark Krul with venture partner Ernst Geutjes, brings decades of cancer research and drug development experience and takes an active, hands-on role in shaping R&D plans from early screeni...
Notable Investments
M
Merus N.V.Similar Funds
AP
AdBio Partners
Paris, France
Pure DeepTechBiotechSynthetic BiologyMedtechSeedSeries A
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
AH
Apollo Health Ventures
Berlin, Germany
Pure DeepTechBiotechSeedSeries A
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantumSemiconductorsSeedSeries A
Flagship Pioneering
Cambridge, United States
Pure DeepTechBiotechAgritechAIPre-SeedSeed
Forbion
Naarden, Netherlands
Pure DeepTechBiotechSynthetic BiologyClimate TechSeedSeries A